Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Disease Browser
Parent Node:
expand
Basal Ganglia Diseases (D001480)
Parent Node:
expand
Neurotoxicity Syndromes (D020258)
..Starting node
..expand
Neuroleptic Malignant Syndrome (D009459)

       Child Nodes:



 Sister Nodes: 
..expandAkathisia, Drug-Induced (D017109)
..expandAlcohol-Induced Disorders, Nervous System (D020268) Child6
..expandBotulism (D001906)
..expandDyskinesia, Drug-Induced (D004409)
..expandHeavy Metal Poisoning, Nervous System (D020260) Child7
..expandMPTP Poisoning (D020267)
..expandNeuroleptic Malignant Syndrome (D009459)
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM, CTD
Term ID:7971
Name:Neuroleptic Malignant Syndrome
Definition:A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
Alternative IDs:
ParentIDs:MESH:D001480|MESH:D020258
TreeNumbers:C10.228.140.079.737 |C10.720.737 |C25.723.705.600
Synonyms:Neuroleptic Induced Neuroleptic Malignant Syndrome |Neuroleptic-Induced Neuroleptic Malignant Syndrome |Neuroleptic Malignant Syndrome, Neuroleptic Induced |Neuroleptic-Malignant Syndrome, Neuroleptic Induced |Neuroleptic Malignant Syndromes |NMS (Neuroleptic
Slim Mappings:Nervous system disease
Reference: MedGen: D009459
MeSH: D009459
OMIM:

Genes:
Phenotypes
Disease Causing ClinVar Variants